ADVANCED MONITORED CAREGIVING INC

ADVANCED MONITORED CAREGIVING INC specializes in remote patient monitoring and technology-enabled home-based caregiving services, leveraging secure, real-time health data collection and clinical oversight systems to support vulnerable populations. Their core capabilities center on deploying wearable biosensors, telehealth platforms, and automated alert protocols that enable continuous clinical monitoring outside traditional care settings. The company integrates FDA-cleared medical devices with HIPAA-compliant data management systems to facilitate early intervention, reduce hospital readmissions, and extend independent living for seniors and individuals with chronic conditions. Technical expertise includes remote vital sign tracking, fall detection analytics, medication adherence monitoring, and integration with electronic health records through HL7 and FHIR standards. Their differentiation lies in operationalizing passive monitoring technologies within community-based care models, emphasizing patient autonomy while maintaining clinical accountability. Award history is not available to confirm specific agency engagements or contract performance. As such, no definitive patterns of agency relationships or mission-specific work can be inferred. The company operates under NAICS 621999, which encompasses other miscellaneous ambulatory health care services, indicating a focus on non-clinical, technology-driven support services that complement traditional home health and personal care. Their market positioning aligns with the growing demand for scalable, low-acuity care solutions that reduce burden on institutional systems while improving quality of life. ADVANCED MONITORED CAREGIVING INC is structured as a small business (2L entity) headquartered in New York, NY, with no federal certifications on record. The company’s geographic footprint is limited to its primary operational base, and its government market presence appears nascent, with no publicly documented contract awards to date. Its business model suggests a readiness to pursue federal or state-funded aging-in-place and chronic disease management initiatives, pending future procurement opportunities.